Figure 3.
Metabolism of givosiran.
Note: Li J, Liu J, Zhang X, et al. Nonclinical pharmacokinetics and absorption, distribution, metabolism, and excretion of givosiran, the first approved N-Acetylgalactosamine-conjugated RNA interference therapeutic. Drug Metab Dispos. 2021;49(7):572–580.51